Matthew Eitner – Chief Executive Officer of Laidlaw & Company UK

Matthew Eitner Laidlaw CEO

Matthew Eitner is the chief executive officer of Laidlaw & Company UK. He specializes in the expansion of equity positions in the healthcare sector and in hiring industry-respected figures as directors of expanded teams.

About Matthew Eitner

Matt Eitner is the chief executive officer of Laidlaw & Company UK, an investment management firm with more than 150 employees in offices across the United States and London. As CEO, and alongside managing partner James Ahern, Eitner has expanded the company’s equity positions in the healthcare sector while hiring industry-respected figures as directors of its expanded teams.

Early Life and Career 

In 1999, Matt Eitner graduated from University of Scranton in Pennsylvania with a degree in business management. He then worked as an equities trader at NDB Capital Markets in Jersey City, NJ from 2000 to 2002. Subsequently, he moved to New York City and served as vice president of Casimir Capital from 2002 to 2008, whereupon he became managing director of Aegis Capital Corp and serving in that role until 2010, when he joined Laidlaw.

Notable Investments

In October 2020, Matthew Eitner’s firm, Laidlaw and Company, acquired Naples Wealth Planning, a $359 million independent consultation firm, and said that it would grow its offshore advisory business by leveraging the firm’s Miami location.

Laidlaw’s Matthew Eitner in the News

In September 2021, Matt Eitner’s firm served as the lead manager for aTyr Pharma’s (LIFE) $86,250,000 public offering of common stock.

In July 2021, Eitner’s firm was the sole book-running manager for BioSig Technologies’s public offering of common stock. BioSig specializes in a biomedical signal processing platform, and Laidlaw had raised about $40 million for the company over the course of a decade.

In March 2021, Eitner’s firm acted as co-manager on a $25 million follow-on offering for iCad, Inc., a tech company that provides cancer detection and therapy solutions. In addition, Eitner’s firm also announced in March 2021 that it had successfully closed a $4 million Series A financing round for its portfolio company, AerWave, which treats asthma, COPD, and lung disease.

More Investors from the Americas

Jett Fein

Jett Fein

Jett Fein is an American investor with major business interests across the globe. Read about his early years and business interests and find out more ...
Investor's Profile →
Patrick Chung

Patrick Chung

Patrick Chung is Managing General Partner of Xfund. Prior to Xfund, Patrick was a partner at NEA and led the firm’s consumer and seed investment ...
Investor's Profile →
Pete Flint

Pete Flint

Pete Flint is a British internet entrepreneur in San Francisco. He is the founder and CEO of Trulia real estate
Investor's Profile →
Pietro Dova

Pietro Dova

Pietro Dova is a former Google executive and the cofounder of XG Ventures (X-Google Ventures), a leading VC firm in the mobile, IT, analytics and ...
Investor's Profile →
Ryan Moore

Ryan Moore

Ryan Moore is a venture capitalist based in Massachusetts in the United States. He is the founder of Accomplice VC, a venture capital firm with ...
Investor's Profile →
Murray Edwards

Murray Edwards

Murray Edwards is a Canadian oil sands investor and businessman ranked by Forbes as one of the top 15 wealthiest people in Canada.
Investor's Profile →
Eduardo Saverin

Eduardo Saverin

Eduardo Saverin, the Brazilian investor and entrepreneur who co-founded Facebook. Find out more about his life and read about the other significant investments he has ...
Investor's Profile →
With an ever-growing collection of investments geared for ecological change, Leonardo DiCaprio has made a strong statement that he is committed to a greener world

Leonardo DiCaprio

Leonardo DiCaprio has made a strong statement that he is committed to a greener world with an ever-growing collection of investments geared for ecological change
Investor's Profile →
Esther Dyson

Esther Dyson

Esther Dyson is the executive founder of Wellville. Read more about this investor, author, journalist, and philanthropist.
Investor's Profile →